PharmacovigilanceOfficial

Pleasanton drug discovery firm Cyion to pay $528,336 over alleged False Claims Act grant violations

🇺🇸 HHS OIG · Mon 16 Nov 2026

Cyion Technologies has agreed to pay $528,335.74 to resolve allegations it drew down federal grant funds it was not eligible to receive, according to HHS OIG.

Cyion Technologies LLC, a Pleasanton, California company involved in biological research and drug discovery, has agreed to pay $528,335.74 to resolve allegations under the False Claims Act. HHS OIG published the item on 16 November 2026, pointing to an announcement from the US Attorney's Office for the Northern District of California dated 13 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Official source: HHS OIG ↗

Article written by VigiEye from the official source (HHS OIG). AI-assisted; check the source before acting.